ClearPoint Neuro, Inc.
CLPT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001285550
In the last 90 days, ClearPoint Neuro, Inc. insiders filed 0 open-market purchases and 1 sale; 128 institutions reported holding it in 13F filings for Q2 2026, worth $247.8M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $387.6K in total
- 1
- 13F holdersQ2 2026, +11 vs. previous quarter
- 128
- 13F valueReported value at the end of Q2 2026
- $247.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CLPT, Q2 2026
No superinvestor reported holding CLPT at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by ClearPoint Neuro, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 (view filing)6:43 PM ET | Jun 29 | 2 days | Burnett Joseph MichaelCEO and President | SSale | −20.0K | $19.38 | −$387.6K | −14.6%116.8K after | 10b5-1 |
| Jun 22, 2026 (view filing) | Jun 17 | 5 days | Burnett Joseph MichaelCEO and President | SSale | −60.0K | $17.79 | −$1.07M | −33.9%116.8K after | 10b5-1 |
| Jun 22, 2026 (view filing) | Jun 17 | 5 days | Burnett Joseph MichaelCEO and President | SSale | −1.84K | $17.94 | −$33.1K | −1.0%191.4K after | 10b5-1 |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Richards Timothy T.Director | SSale | −5.42K | $12.17 | −$65.9K | −5.8%87.2K after | |
| May 26, 2026 (view filing) | May 21 | 5 days | Klein Matthew B.Director | SSale | −16.0K | $11.59 | −$185.4K | −25.4%46.9K after | |
| May 21, 2026 (view filing) | May 20 | 1 day | Fallon Lynnette CDirector | SSale | −5.09K | $11.14 | −$56.7K | −9.5%48.2K after | 10b5-1 |
| Feb 26, 2026 (view filing) | Feb 25 | 1 day | Burnett Joseph MichaelCEO and President | SSale | −20.0K | $15.17 | −$302.7K | −9.4%193.2K after | 10b5-1 |
| Jan 27, 2026 (view filing) | Jan 26 | 1 day | Burnett Joseph MichaelCEO and President | SSale | −2.94K | $15.57 | −$45.8K | −1.4%214.1K after | 10b5-1 |
| Jan 13, 2026 (view filing) | Jan 9 | 4 days | Burnett Joseph MichaelCEO and President | SSale | −20.0K | $16.12 | −$322.4K | −63.4%11.6K after | 10b5-1 |
| Oct 14, 2025 (view filing) | Oct 10 | 4 days | Burnett Joseph MichaelCEO and President | SSale | −26.5K | $26.98 | −$714.0K | −10.9%217.1K after | 4 lots10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in ClearPoint Neuro, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,379,804 | $42.5M | 0.00% | +297,054+14.3% | Added |
| Mak Capital One LLC | 2,375,861 | $42.4M | 5.94% | +474,372+24.9% | Added |
| Vanguard Capital Management LLC | 1,232,807 | $22.0M | 0.00% | −10,808−0.9% | Reduced |
| State Street Corp | 816,547 | $14.6M | 0.00% | +136,728+20.1% | Added |
| Geode Capital Management, LLC | 749,932 | $13.4M | 0.00% | +44,212+6.3% | Added |
| Lane Generational LLC | 444,831 | $7.94M | 6.97% | −42,018−8.6% | Reduced |
| UBS Group AG | 428,632 | $7.65M | 0.00% | −3,728−0.9% | Reduced |
| Millennium Management LLC | 357,676 | $6.38M | 0.00% | +125,702+54.2% | Added |
| Brown Advisory Inc | 325,906 | $5.81M | 0.01% | 00.0% | Unchanged |
| Compass Financial Management LLC | 295,680 | $5.27M | 0.64% | +295,680 | New |